36
1
12
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T12730 | RIPK1-IN-4 | RIP kinase | |
RIPK1-IN-4 is a potent and selective type II kinase receptor interacting protein 1 (RIP1) kinase inhibitor and binds to a DLG-out inactive form of RIP1 (IC50s of 16 nM and 10 nM for RIP1 and ADP-Glo kinase). | |||
T12731 | RIPK1-IN-7 | RIP kinase | |
RIPK1-IN-7 is a potent and selective inhibitor of RIPK1(Kd of 4 nM and an enzymatic IC50 of 11 nM),andexhibits excellent antimetastasis activity in the experimental B16 melanoma lung metastasis model. | |||
T63055 | RIPK1-IN-9 | RIP kinase | |
RIPK1-IN-9 is a potent and selective inhibitor of RIPK1, a dihydronaphthone compound, which inhibits U937 and L929 cells with an IC50 of 2 nM and 1.3 nM, respectively. | |||
T12729 | RIPK1-IN-3 | Others | |
RIPK1-IN-3 is a RIPK1 inhibitor, with anti-inflammatory proprieties. | |||
T81268 | RIPK1-IN-17 | RIP kinase | |
RIPK1/3-IN-1 (Compound 10) is a selective inhibitor of both RIPK1 and RIPK3, effectively preventing necroptosis by blocking the phosphorylation of RIPK1, RIPK3, and MLKL [1]. | |||
T64064 | RIPK1-IN-10 | ||
RIPK1-IN-10 is a potent inhibitor of RIPK1. | |||
T61887 | RIPK1-IN-13 | ||
RIPK1-IN-13 (Compound 8) is an effective RIPK1 inhibitor (IC50=1139 nM). By inhibiting RIPK1, RIPK1-IN-13 can block the activation of necrotic apoptosis pathway. RIPK1-IN-13 has research potential in inflammatory disease... | |||
T63469 | RIPK1-IN-8 | ||
RIPK1-IN-8 is an aminoimidazolopyridine and is a selective and potent inhibitor of RIPK1 (IC50: 4 nM).RIPK1-IN-8 has research potential in inflammatory diseases. | |||
T81269 | RIPK1-IN-16 | RIP kinase | |
RIPK1-IN-16 is an orally active, potent RIPK1 inhibitor that mitigates excessive inflammation via inhibition of RIPK1-mediated necroptosis in vivo. It shields mice from TNF-induced systemic inflammatory response syndrome... | |||
T62499 | RIPK1-IN-14 | ||
RIPK1-IN-14 (Compound 41) is a potent inhibitor of RIPK1 (IC50: 92 nM).RIPK1-IN-14 has a significant anti-necrotic apoptotic effect in a model of necrotic apoptosis in U937 cells. | |||
T62762 | RIPK1-IN-11 | ||
RIPK1-IN-11 is an orally active RIPK1 inhibitor with a Kd value of 9.2 nM and an IC50 value of 67 nM. RIPK1-IN-11 inhibits necrosis in human and mouse cells and exhibits anti-inflammatory effects. | |||
T62723 | RIPK1-IN-12 | ||
RIPK1-IN-12 is a potent inhibitor of RIPK1, which exhibits an inhibitory effect on necroptosis in human and mouse cells with EC50 values of 1.6 and 2.9 nM, respectively. | |||
T60862 | RIPK1-IN-15 | ||
RIPK1-IN-15 (Compound 2.5) is a potent RIPK1 inhibitor that has the potential in neurodegenerative, autoimmune, and inflammatory diseases research [1]. | |||
T12493 | PK68 | Others , RIP kinase | |
PK68 is an effective and selective inhibitor of type II receptor-interacting kinase 1 (RIPK1, IC50 = 90 nM). PK68 can be used for research on the treatment of inflammatory disorders and cancer metastasis. | |||
T9095 | Necrostatin-34 | 2-{[3-cyano-4-(4-methylphenyl)-6-oxo-1,4 | RIP kinase |
Necrostatin-34 (2-{[3-cyano-4-(4-methylphenyl)-6-oxo-1,4) is a RIPK1 kinase inhibitor, stabilizing RIPK1 kinase in an inactive conformation by occupying a distinct binding pocket in the kinase domain. | |||
T9079 | Apostatin-1 | Apt-1 | Others |
Apostatin-1 (Apt-1) is a novel TRADD inhibitor. Apostatin-1 can bind to a pocket on the N-terminal TRAF2 binding domain of TRADD. | |||
T8931L | ICCB-19 hydrochloride | ICCB-19 HCl(750621-52-4 free base) | Apoptosis , Others , Autophagy , RIP kinase |
ICCB-19 hydrochloride (ICCB-19 HCl) is an inhibitor of TRADD (TNFRSF1A Associated Via Death Domain). It binds to a pocket on the N-terminal TRAF2-binding domain of TRADD (TRADD-N), which interacts with the C-terminal dom... | |||
T7504 | Necrostatin 2 racemate | Necrostatin-2 racemate | RIP kinase |
Necrostatin 2 racemate (Necrostatin-2 racemate) is an potent and specific inhibitor of RIPK1. | |||
T9702 | Eclitasertib | RIP kinase | |
Eclitasertib is a potent inhibitor of receptor-interacting protein kinase 1 (RIPK1, IC50 of <1 µΜ). | |||
T9305 | Necroptosis-IN-1 | RIP kinase | |
Necroptosis-IN-1 is a potent necroptosis inhibitor of RIPK1. It is an analog of Necrostatin-1. | |||
T15437 | GSK3145095 | RIP kinase | |
GSK3145095 is an orally active inhibitor of RIPK1 with IC50 of 5 nM, with potential immunomodulatory activities and antineoplastic. | |||
T7151 | GSK2982772 | RIP kinase | |
GSK2982772 is an inhibitor of receptor interacting serine/threonine kinase 1 (RIPK1)with IC50 values of 16 nM and 20 nM for human and monkey RIP1, respectively. | |||
T63544 | RIPK3-IN-1 | ||
RIPK3-IN-1 is a type II RIPK3DFG-out site inhibitor (IC50: 9.1 nM) that inhibits RIPK1 (IC50: 5.5 μM) and RIPK2 (IC50>10 μM). RIPK3-IN-1 is a c-Met kinase inhibitor (IC50: 1.1 μM). | |||
T73511 | SZM679 | RIP kinase | |
SZM679 is an orally active, selective RIPK1 inhibitor displaying potent affinity with a dissociation constant (Kd) of 8.6 nM for RIPK1, while exhibiting minimal activity towards RIPK3, with a Kd of >5000 nM. It effective... | |||
T73382 | SZM-1209 | RIP kinase | |
SZM-1209 is a potent and specific RIPK1 inhibitor with oral activity, displaying a dissociation constant (Kd) of 85 nM. It demonstrates substantial anti-necroptotic efficacy with an EC50 of 22.4 ± 8.1 nM and possesses th... | |||
T73373 | TP-030-2 | ||
TP-030-2 is a RIPK1 inhibitor (human K i =0.43 nM ; mouse IC 50 =100 nM) . | |||
T73374 | TP-030-1 | ||
TP-030-1, an inhibitor of RIPK1, exhibits potent activity against hRIPK1 (human RIPK1) with a Ki value of 3.9 nM and against mRIPK1 (mouse RIPK1) with an IC50 value of 4.2 μM. This compound is instrumental in the researc... | |||
T68520 | Cl-Necrostatin-1 | ||
Cl-Necrostatin-1 is an inhibitor of receptor-interacting protein kinase. It inhibits RIPK1 activity. | |||
T12203L | Necrostatin 2 | Others | |
Necrostatin 2 is an effective necroptosis inhibitor. Necrostatin 2 is also a RIPK1 inhibitor. EC50 for inhibition of necroptosis in FADD-deficient Jurkat T cells treated with TNF-α is 0.05 μM. | |||
T69726 | Oditrasertib | ||
Oditrasertib, a RIPK1 inhibitor characterized by an IC50 value below 100 nM, is employed in inflammation research. | |||
T74801 | KWCN-41 | ||
KWCN-41, a selective and efficient RIPK1 kinase inhibitor, exhibits an IC50 value of 88 nM. It specifically targets cell necrosis without affecting apoptosis and possesses anti-inflammatory properties [1]. | |||
T73493 | RI-962 | RIP kinase | |
RI-962 is a potent and selective inhibitor of receptor-interacting protein kinase 1 (RIPK1), exhibiting an IC50 of 35.0 nM. It is utilized for the investigation of nervous system disorders and inflammatory diseases [1]. | |||
T74642 | DB1113 | ||
DB1113 (Example 24) is a bifunctional compound designed for the targeted degradation of various kinases. It effectively degrades a range of kinases, including ABL1, ABL2, BLK, CDK11B, CDK4, CSK, EPHA3, FER, GAK, LIMK1, M... | |||
T60316 | AV123 | ||
AV123 (compound 12) is a non-cytotoxic RIPK1 inhibitor with IC 50 of 12.12 μM. AV123 blocks the TNF-α-induced necroptotic with EC 50 of 1.7 μM, but not the apoptotic cell death. AV123 can be used in the study of necrotic... | |||
T79041 | RIP1 kinase inhibitor 4 | RIP kinase | |
RIP1 Kinase Inhibitor 4 (Compound 3) is an effective inhibitor of RIP1K, exhibiting an EC50 of ≤ 1000 nM [1]. | |||
T74644 | DB0614 | ||
DB0614 (Example 21) is a bifunctional compound designed for the targeted degradation of kinases, effectively breaking down a wide array of kinases including AAK1, AURKA, BMP2K, CAMKK1, CDK16, CML, CDK6, EIF2AK2, FER, GAK... |
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T6S1255 | Ophiopogonin-D | ROS | |
Ophiopogonin D(OPD) significantly inhibited the in vitro and in vivo growth of prostate cells via RIPK1, OPD may be developed as a potential anti-prostate cancer agent. |
Cat No. | Product Name | Species | Expression System |
---|---|---|---|
TMPH-02876 | RIPK1 Protein, Mouse, Recombinant (His) | Mouse | E. coli |
Serine-threonine kinase which is a key regulator of TNF-mediated apoptosis, necroptosis and inflammatory pathways. Exhibits kinase activity-dependent functions that regulate cell death and kinase-independent scaffold fun... | |||
TMPH-02007 | RIPK1 Protein, Human, Recombinant (His & Myc) | Human | E. coli |
RIPK1 Protein, Human, Recombinant (His & Myc) is expressed in E. coli. | |||
TMPY-02213 | RAIDD Protein, Human, Recombinant (His) | Human | E. coli |
Death domain-containing protein CRADD, also known as Caspase and RIP adapter with death domain, RIP-associated protein with a death domain, CRADD and RAIDD, is a protein which is constitutively expressed in most tissu... | |||
TMPH-02877 | RIPK3 Protein, Mouse, Recombinant (His) | Mouse | Yeast |
Serine/threonine-protein kinase that activates necroptosis and apoptosis, two parallel forms of cell death. Necroptosis, a programmed cell death process in response to death-inducing TNF-alpha family members, is triggere... | |||
TMPH-00839 | RIPK3 Protein, Human, Recombinant (His & SUMO) | Human | E. coli |
Serine/threonine-protein kinase that activates necroptosis and apoptosis, two parallel forms of cell death. Necroptosis, a programmed cell death process in response to death-inducing TNF-alpha family members, is triggere... | |||
TMPH-01264 | PELI1 Protein, Human, Recombinant (His) | Human | Baculovirus |
E3 ubiquitin ligase catalyzing the covalent attachment of ubiquitin moieties onto substrate proteins. Involved in the TLR and IL-1 signaling pathways via interaction with the complex containing IRAK kinases and TRAF6. Me... | |||
TMPY-01654 | ITCH Protein, Human, Recombinant (aa 526-903) | Human | E. coli |
E3 ubiquitin-protein ligase Itchy homolog, also known as Atrophin-1-interacting protein 4, NFE2-associated polypeptide 1, NAPP1, and ITCH, is a cell membrane protein that contains one C2 domain, one HECT (E6AP-type E3 ub... | |||
TMPH-01531 | IKBKB Protein, Human, Recombinant (His) | Human | Baculovirus |
Serine kinase that plays an essential role in the NF-kappa-B signaling pathway which is activated by multiple stimuli such as inflammatory cytokines, bacterial or viral products, DNA damages or other cellular stresses. A... | |||
TMPH-01532 | IKBKB Protein, Human, Recombinant (E. coli, His) | Human | E. coli |
Serine kinase that plays an essential role in the NF-kappa-B signaling pathway which is activated by multiple stimuli such as inflammatory cytokines, bacterial or viral products, DNA damages or other cellular stresses. A... | |||
TMPH-02194 | TAB2 Protein, Human, Recombinant (His & Myc) | Human | Baculovirus |
Adapter required to activate the JNK and NF-kappa-B signaling pathways through the specific recognition of 'Lys-63'-linked polyubiquitin chains by its RanBP2-type zinc finger (NZF). Acts as an adapter linking MAP3K7/TAK1... | |||
TMPJ-01328 | ZBP1 Protein, Human, Recombinant (His) | Human | E. coli |
Z-DNA Binding Protein 1 (ZBP1) is a protein with 2 DRADA repeats. ZBP1 is highly expressed in lymphatic tissues including lymph node, leukocytes, tonsil, bone marrow, and spleen. ZBP1 participates in the detection of vir... | |||
TMPH-01057 | Caspase-8 Protein, Human, Recombinant (His) | Human | E. coli |
Thiol protease that plays a key role in programmed cell death by acting as a molecular switch for apoptosis, necroptosis and pyroptosis, and is required to prevent tissue damage during embryonic development and adulthood... |